137MO Phase II Study of Becotarug (JMT101) Combined with Osimertinib in Patients (pts) with Locally Advanced or Metastatic NSCLC Harboring EGFR Exon 20 Insertion (ex20ins) Mutations (BECOME Study)

L. Zhang, W. Fang, S. Zhao, Y. Yu, X. Tang, X. Dong,W. Zhuang, Y. Hu,F. Luo, Q. Wang,Q. Chu,Z. Fu, Y. Yao, X. Ma,C. Ding,J. Hao, X. Wan, M. Li, Y. Yang, X. Yang

ESMO Open（2024）

Cited 0|Views17

No score

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined